AstraZeneca Pre-Tax Income 2010-2024 | AZN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual pre-tax income for 2023 was $6.899B, a 175.85% increase from 2022.
AstraZeneca annual pre-tax income for 2022 was $2.501B, a 1043.77% decline from 2021.
AstraZeneca annual pre-tax income for 2021 was $-0.265B, a 106.77% decline from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual pre-tax income for 2023 was $6.899B, a 175.85% increase from 2022.
AstraZeneca annual pre-tax income for 2022 was $2.501B, a 1043.77% decline from 2021.
AstraZeneca annual pre-tax income for 2021 was $-0.265B, a 106.77% decline from 2020.